Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Devonian Health Group Inc V.GSD

Alternate Symbol(s):  DVHGF

Healthcare
Devonian Health Group Inc. is a Canada-based late-stage botanical pharmaceutical company. The Company is focused on developing prescription botanical drugs from plant materials and algae for the treatment of inflammatory autoimmune diseases, including but not limited to ulcerative colitis and atopic dermatitis. It is also involved in the development of high-value cosmeceutical products leveraging the same proprietary approach employed with their pharmaceutical offerings. Its flagship product, Thykamine, is a pharmaceutical product issued from its SUPREX platform, for the prevention and treatment of health conditions related to inflammation and oxidative stress, including ulcerative colitis, atopic dermatitis, psoriasis, and other autoimmune diseases. Its cosmeceutical products include R-Spinasome and Purgenesis. Its subsidiary, Altius Healthcare Inc., is focused on selling prescription pharmaceutical products in Canada, under license from brand name pharmaceutical companies.


TSXV:GSD - Post by User

Devonian Health Group Inc
Bullboard Posts
User Avatar Image
(1)
•••
Post by w5ivgeon Jul 31, 2020 3:35pm
77 Views
Post# 31351674

S.O.S

S.O.SWOW!!! 10 years options at .15 thats not very reassuring for the shareolders.Lets hope something concrete can be annouced so this ship can sail. GLTA
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities